Upstream Bio, Inc.
UPB
$8.56
-$0.09-1.04%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -7.67% | 0.99% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -7.67% | 0.99% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -7.67% | 0.99% | |||
| SG&A Expenses | 31.49% | 26.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 20.97% | 38.11% | |||
| Operating Income | -21.64% | -39.30% | |||
| Income Before Tax | -28.38% | -32.83% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -28.38% | -32.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -28.38% | -32.83% | |||
| EBIT | -21.64% | -39.30% | |||
| EBITDA | -21.70% | -39.14% | |||
| EPS Basic | -6.67% | 93.15% | |||
| Normalized Basic EPS | -9.43% | 91.21% | |||
| EPS Diluted | -6.67% | 93.15% | |||
| Normalized Diluted EPS | -9.43% | 91.21% | |||
| Average Basic Shares Outstanding | 17.32% | 1,411.70% | |||
| Average Diluted Shares Outstanding | 17.32% | 1,411.70% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||